CYTEK BIOSCIENCES, INC. Operating Leases, Rent Expense
CYTEK BIOSCIENCES, INC. (CTKB) reported Operating Leases, Rent Expense of $2.10 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2022-03-17
- CYTEK BIOSCIENCES, INC. operating leases, rent expense for the quarter ending 2021-12-31 was $800.00K, a 104.60% increase year-over-year.
- CYTEK BIOSCIENCES, INC. operating leases, rent expense for the quarter ending 2021-09-30 was $442.00K, a 31.94% increase year-over-year.
- CYTEK BIOSCIENCES, INC. operating leases, rent expense for the quarter ending 2021-06-30 was $424.00K, a 54.18% increase year-over-year.
- CYTEK BIOSCIENCES, INC. operating leases, rent expense for the quarter ending 2021-03-31 was $434.00K.
- CYTEK BIOSCIENCES, INC. operating leases, rent expense for fiscal 2021 was $2.10M, a 61.54% increase from fiscal 2020.
- CYTEK BIOSCIENCES, INC. operating leases, rent expense for fiscal 2020 was $1.30M.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|
| 2021-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $1.24M derived: sum of 2 quarters · filed 2022-03-17 | $1.67M derived: sum of 3 quarters · filed 2022-03-17 | $2.10M 10-K · filed 2022-03-17 |
| 2021-09-30 | $442.00K 10-Q · filed 2021-11-12 | $866.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.30M 10-Q · filed 2021-11-12 | $1.69M derived: sum of 4 quarters · filed 2022-03-17 |
| 2021-06-30 | $424.00K 10-Q · filed 2021-09-03 | $839.00K 10-Q · filed 2021-09-03 | $1.25M derived: sum of 3 quarters · filed 2022-03-17 | $1.58M derived: sum of 4 quarters · filed 2022-03-17 |
| 2021-03-31 | $434.00K derived: 10-K 12 month − 3 quarters · filed 2022-03-17 | $825.00K derived: sum of 2 quarters · filed 2022-03-17 | $1.16M derived: sum of 3 quarters · filed 2022-03-17 | $1.44M derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-12-31 | $391.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $726.00K derived: sum of 2 quarters · filed 2022-03-17 | $1.00M derived: sum of 3 quarters · filed 2022-03-17 | $1.30M 10-K · filed 2022-03-17 |
| 2020-09-30 | $335.00K 10-Q · filed 2021-11-12 | $610.00K derived: sum of 2 quarters · filed 2021-11-12 | $909.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $275.00K 10-Q · filed 2021-09-03 | $577.00K 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |